Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Peter, Lugomirski"'
Autor:
George Wells, Marino Labinaz, Jordan Bernick, Benjamin Hibbert, Alexander Dick, Ali Pourdjabbar, Derek So, Michael Froeschl, Aun-Yeong Chong, Peter Lugomirski, Christopher Glover, Michel R. Le May, Trevor Simard, Jean-Francois Marquis, Ronnen Maze, F. Daniel Ramirez
Publikováno v:
Thrombosis and Haemostasis. 117:303-310
SummaryTicagrelor has been endorsed by guidelines as the P2Y12 inhibitor of choice in patients with acute coronary syndrome. Clinically, some patients on ticagrelor will require a switch to clopidogrel; however, the optimal strategy and pharmacodynam
Publikováno v:
Canadian Journal of Cardiology. 29:1382-1387
Background There has been significant attention to the quality of care for acute myocardial infarction (MI). However, little is known about the quality of preventive care before a patient's first MI. Methods We conducted a retrospective, cohort analy
Publikováno v:
Expert Review of Cardiovascular Therapy. 12:1247-1249
Single photon emission computed tomography myocardial perfusion imaging is a powerful modality for the assessment of coronary artery disease. It is useful in the diagnosis of CAD, prognostication of CAD and the determination of viability. It acts as
Publikováno v:
The Journal of invasive cardiology. 27(9)
Direct stenting (DS) is commonly used during percutaneous coronary intervention for acute myocardial infarction (AMI) to prevent distal embolization; however, no guideline recommendations exist regarding DS. We sought to compare DS with conventional
Publikováno v:
JACC: Cardiovascular Interventions. 8(10):e159-e160
An 87-year-old female patient had an uncomplicated Medtronic CoreValve transcatheter aortic valve replacement (TAVR) (Medtronic, Minneapolis, Minnesota) ([Figure 1][1], [Online Video 1][2]). The 29-mm CoreValve was correctly sized on the basis of the
Autor:
George A. Wells, Aun-Yeong Chong, Alexander Dick, Jean-Francois Marquis, Derek So, F. Daniel Ramirez, Michael Froeschl, Benjamin Hibbert, Ronnen Maze, Christopher Glover, Ali Pourdjabbar, Trevor Simard, Peter Lugomirski, Marino Labinaz, Michel R. Le May
Publikováno v:
Journal of the American College of Cardiology. 65:A108
Ticagrelor is commonly used as the P2Y12 inhibitor of choice in patients with acute coronary syndrome (ACS). Despite being superior to clopidogrel, clinicians may need to switch to a less potent P2Y12 inhibitor because of increased risk of bleeding,
Publikováno v:
Canadian Journal of Cardiology. 29:S337
Publikováno v:
Canadian Journal of Cardiology. 28:S184